false Q1 2023 0000913277 Yes Yes 2023-02-01 2024-02-01 2024-02-01 P13Y P10Y P10Y2M12D P13Y9M18D P9Y4M24D P13Y P10Y P10Y2M12D P13Y9M18D P9Y4M24D 0000913277 us-gaap:TreasuryStockMember 2023-01-01 2023-03-31 0000913277 us-gaap:TreasuryStockMember 2022-01-01 2022-03-31 0000913277 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000913277 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000913277 us-gaap:TreasuryStockMember 2023-03-31 0000913277 us-gaap:RetainedEarningsMember 2023-03-31 0000913277 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000913277 us-gaap:TreasuryStockMember 2022-12-31 0000913277 us-gaap:RetainedEarningsMember 2022-12-31 0000913277 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000913277 us-gaap:TreasuryStockMember 2022-03-31 0000913277 us-gaap:RetainedEarningsMember 2022-03-31 0000913277 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000913277 us-gaap:TreasuryStockMember 2021-12-31 0000913277 us-gaap:RetainedEarningsMember 2021-12-31 0000913277 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000913277 us-gaap:CommonStockMember 2023-03-31 0000913277 us-gaap:CommonStockMember 2022-12-31 0000913277 us-gaap:CommonStockMember 2022-03-31 0000913277 us-gaap:CommonStockMember 2021-12-31 0000913277 srt:MinimumMember us-gaap:RestrictedStockMember bde:TwoThousandFifteenStockIncentivePlanMember 2023-03-14 2023-03-14 0000913277 srt:MaximumMember us-gaap:RestrictedStockMember bde:TwoThousandFifteenStockIncentivePlanMember 2023-03-14 2023-03-14 0000913277 us-gaap:RestrictedStockMember bde:TwoThousandFifteenStockIncentivePlanMember 2023-03-14 0000913277 us-gaap:RestrictedStockMember bde:TwoThousandFifteenStockIncentivePlanMember bde:VestingThresholdTwoMember 2023-03-14 2023-03-14 0000913277 us-gaap:RestrictedStockMember bde:TwoThousandFifteenStockIncentivePlanMember bde:VestingThresholdOneMember 2023-03-14 2023-03-14 0000913277 us-gaap:RestrictedStockMember bde:TwoThousandFifteenStockIncentivePlanMember 2023-03-14 2023-03-14 0000913277 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000913277 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000913277 bde:InternationalSalesRevenueMember bde:PrecisionSportSegmentMember 2023-01-01 2023-03-31 0000913277 bde:InternationalSalesRevenueMember bde:OutdoorSegmentMember 2023-01-01 2023-03-31 0000913277 bde:InternationalSalesRevenueMember bde:AdventureSegmentMember 2023-01-01 2023-03-31 0000913277 bde:DomesticSalesRevenueMember bde:PrecisionSportSegmentMember 2023-01-01 2023-03-31 0000913277 bde:DomesticSalesRevenueMember bde:OutdoorSegmentMember 2023-01-01 2023-03-31 0000913277 bde:DomesticSalesRevenueMember bde:AdventureSegmentMember 2023-01-01 2023-03-31 0000913277 bde:InternationalSalesRevenueMember 2023-01-01 2023-03-31 0000913277 bde:DomesticSalesRevenueMember 2023-01-01 2023-03-31 0000913277 bde:InternationalSalesRevenueMember bde:PrecisionSportSegmentMember 2022-01-01 2022-03-31 0000913277 bde:InternationalSalesRevenueMember bde:OutdoorSegmentMember 2022-01-01 2022-03-31 0000913277 bde:InternationalSalesRevenueMember bde:AdventureSegmentMember 2022-01-01 2022-03-31 0000913277 bde:DomesticSalesRevenueMember bde:PrecisionSportSegmentMember 2022-01-01 2022-03-31 0000913277 bde:DomesticSalesRevenueMember bde:OutdoorSegmentMember 2022-01-01 2022-03-31 0000913277 bde:DomesticSalesRevenueMember bde:AdventureSegmentMember 2022-01-01 2022-03-31 0000913277 bde:InternationalSalesRevenueMember 2022-01-01 2022-03-31 0000913277 bde:DomesticSalesRevenueMember 2022-01-01 2022-03-31 0000913277 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000913277 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000913277 us-gaap:MachineryAndEquipmentMember 2023-03-31 0000913277 us-gaap:LandMember 2023-03-31 0000913277 us-gaap:FurnitureAndFixturesMember 2023-03-31 0000913277 us-gaap:ConstructionInProgressMember 2023-03-31 0000913277 us-gaap:BuildingAndBuildingImprovementsMember 2023-03-31 0000913277 bde:ComputerHardwareAndSoftwareMember 2023-03-31 0000913277 us-gaap:MachineryAndEquipmentMember 2022-12-31 0000913277 us-gaap:LandMember 2022-12-31 0000913277 us-gaap:FurnitureAndFixturesMember 2022-12-31 0000913277 us-gaap:ConstructionInProgressMember 2022-12-31 0000913277 us-gaap:BuildingAndBuildingImprovementsMember 2022-12-31 0000913277 bde:ComputerHardwareAndSoftwareMember 2022-12-31 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2023-01-01 2023-03-31 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-03-31 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-01-01 2022-03-31 0000913277 bde:OperatingLossCarryforwardExpirationYear2025AndBeyondMember 2022-12-31 0000913277 bde:OperatingLossCarryforwardExpirationYear2024Member 2022-12-31 0000913277 bde:OperatingLossCarryforwardExpirationYear2023Member 2022-12-31 0000913277 bde:OperatingLossCarryforwardExpirationYear2022Member 2022-12-31 0000913277 us-gaap:OperatingSegmentsMember bde:PrecisionSportSegmentMember 2023-01-01 2023-03-31 0000913277 us-gaap:OperatingSegmentsMember bde:OutdoorSegmentMember 2023-01-01 2023-03-31 0000913277 us-gaap:OperatingSegmentsMember bde:AdventureSegmentMember 2023-01-01 2023-03-31 0000913277 us-gaap:OperatingSegmentsMember 2023-01-01 2023-03-31 0000913277 us-gaap:OperatingSegmentsMember bde:PrecisionSportSegmentMember 2022-01-01 2022-03-31 0000913277 us-gaap:OperatingSegmentsMember bde:OutdoorSegmentMember 2022-01-01 2022-03-31 0000913277 us-gaap:OperatingSegmentsMember bde:AdventureSegmentMember 2022-01-01 2022-03-31 0000913277 us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0000913277 bde:TermFacilityMember 2023-03-31 0000913277 bde:TermFacilityMember 2022-12-31 0000913277 us-gaap:LetterOfCreditMember bde:RestatedCreditAgreementMember 2023-03-31 0000913277 srt:MinimumMember bde:ForeignCreditFacilityMember 2023-03-31 0000913277 srt:MaximumMember bde:ForeignCreditFacilityMember 2023-03-31 0000913277 bde:TermFacilityMember bde:RestatedCreditAgreementMember 2023-03-31 0000913277 us-gaap:RevolvingCreditFacilityMember bde:RestatedCreditAgreementMember 2022-12-31 0000913277 srt:MinimumMember bde:ForeignCreditFacilityMember 2022-12-31 0000913277 srt:MaximumMember bde:ForeignCreditFacilityMember 2022-12-31 0000913277 bde:TermFacilityMember bde:RestatedCreditAgreementMember 2022-12-31 0000913277 bde:TermFacilityMember bde:RestatedCreditAgreementMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2023-01-01 2023-03-31 0000913277 bde:TermFacilityMember bde:RestatedCreditAgreementMember us-gaap:DebtInstrumentRedemptionPeriodOneMember 2023-01-01 2023-03-31 0000913277 us-gaap:RevolvingCreditFacilityMember bde:RestatedCreditAgreementMember 2023-03-31 0000913277 us-gaap:RevolvingCreditFacilityMember 2023-03-31 0000913277 bde:ForeignCreditFacilityMember 2023-03-31 0000913277 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0000913277 bde:ForeignCreditFacilityMember 2022-12-31 0000913277 bde:SierraTrademarkMember 2023-03-31 0000913277 bde:RhinoRackTrademarkMember 2023-03-31 0000913277 bde:PiepsTrademarkMember 2023-03-31 0000913277 bde:MaxtraxTrademarkMember 2023-03-31 0000913277 bde:BlackDiamondTrademarkMember 2023-03-31 0000913277 bde:BarnesTrademarkMember 2023-03-31 0000913277 bde:SierraTrademarkMember 2022-12-31 0000913277 bde:RhinoRackTrademarkMember 2022-12-31 0000913277 bde:PiepsTrademarkMember 2022-12-31 0000913277 bde:MaxtraxTrademarkMember 2022-12-31 0000913277 bde:BlackDiamondTrademarkMember 2022-12-31 0000913277 bde:BarnesTrademarkMember 2022-12-31 0000913277 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2023-01-01 2023-03-31 0000913277 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-01-01 2022-03-31 0000913277 us-gaap:TrademarksAndTradeNamesMember 2023-01-01 2023-03-31 0000913277 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-03-31 0000913277 bde:ProductTechnologiesMember 2023-01-01 2023-03-31 0000913277 bde:CoreTechnologiesMember 2023-01-01 2023-03-31 0000913277 us-gaap:TrademarksAndTradeNamesMember 2022-01-01 2022-12-31 0000913277 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0000913277 bde:ProductTechnologiesMember 2022-01-01 2022-12-31 0000913277 bde:CoreTechnologiesMember 2022-01-01 2022-12-31 0000913277 2022-01-01 2022-12-31 0000913277 us-gaap:TrademarksAndTradeNamesMember 2023-03-31 0000913277 us-gaap:CustomerRelationshipsMember 2023-03-31 0000913277 bde:ProductTechnologiesMember 2023-03-31 0000913277 bde:CoreTechnologiesMember 2023-03-31 0000913277 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0000913277 us-gaap:CustomerRelationshipsMember 2022-12-31 0000913277 bde:ProductTechnologiesMember 2022-12-31 0000913277 bde:CoreTechnologiesMember 2022-12-31 0000913277 us-gaap:FairValueInputsLevel2Member 2023-03-31 0000913277 bde:MaxtraxMember bde:ContingentConsiderationMember 2022-12-31 0000913277 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000913277 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000913277 currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-03-31 0000913277 currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-12-31 0000913277 currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-12-31 0000913277 srt:MaximumMember 2023-01-01 2023-03-31 0000913277 currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000913277 currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000913277 currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000913277 us-gaap:RevolvingCreditFacilityMember bde:RestatedCreditAgreementMember 2023-01-01 2023-03-31 0000913277 us-gaap:RevolvingCreditFacilityMember bde:ForeignCreditFacilityMember 2023-01-01 2023-03-31 0000913277 bde:TermFacilityMember bde:ForeignCreditFacilityMember 2023-01-01 2023-03-31 0000913277 bde:RestatedCreditAgreementMember 2023-01-01 2023-03-31 0000913277 bde:TermFacilityMember bde:RestatedCreditAgreementMember 2023-01-01 2023-03-31 0000913277 us-gaap:SubsequentEventMember 2023-04-28 2023-04-28 0000913277 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0000913277 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000913277 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000913277 2022-03-31 0000913277 2021-12-31 0000913277 srt:MinimumMember bde:ContingentConsiderationMember 2023-03-31 0000913277 srt:MaximumMember bde:ContingentConsiderationMember 2023-03-31 0000913277 us-gaap:FairValueInputsLevel3Member 2023-03-31 0000913277 us-gaap:FairValueInputsLevel1Member 2023-03-31 0000913277 us-gaap:FairValueInputsLevel3Member 2022-12-31 0000913277 us-gaap:FairValueInputsLevel2Member 2022-12-31 0000913277 us-gaap:FairValueInputsLevel1Member 2022-12-31 0000913277 us-gaap:CorporateMember 2023-03-31 0000913277 bde:PrecisionSportSegmentMember 2023-03-31 0000913277 bde:OutdoorSegmentMember 2023-03-31 0000913277 bde:AdventureSegmentMember 2023-03-31 0000913277 us-gaap:CorporateMember 2022-12-31 0000913277 bde:PrecisionSportSegmentMember 2022-12-31 0000913277 bde:OutdoorSegmentMember 2022-12-31 0000913277 bde:AdventureSegmentMember 2022-12-31 0000913277 bde:PrecisionSportSegmentMember 2023-01-01 2023-03-31 0000913277 bde:OutdoorSegmentMember 2023-01-01 2023-03-31 0000913277 bde:AdventureSegmentMember 2023-01-01 2023-03-31 0000913277 bde:PrecisionSportSegmentMember 2022-01-01 2022-03-31 0000913277 bde:OutdoorSegmentMember 2022-01-01 2022-03-31 0000913277 bde:AdventureSegmentMember 2022-01-01 2022-03-31 0000913277 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2023-03-31 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2023-03-31 0000913277 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2022-12-31 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-12-31 0000913277 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2022-03-31 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2022-03-31 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-03-31 0000913277 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2021-12-31 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-12-31 0000913277 2023-04-26 0000913277 2023-03-14 0000913277 bde:RestatedCreditAgreementMember 2023-03-31 0000913277 us-gaap:AustralianTaxationOfficeMember 2023-03-31 0000913277 bde:InlandRevenueDepartmentNewZealandMember 2023-03-31 0000913277 bde:AustrianMinistryOfFinanceMember 2023-03-31 0000913277 bde:MaxtraxMember bde:ContingentConsiderationMember 2023-01-01 2023-03-31 0000913277 2018-08-06 2018-08-06 0000913277 us-gaap:RestrictedStockMember bde:TwoThousandFifteenStockIncentivePlanMember bde:VestingThresholdTwoMember 2023-03-14 0000913277 us-gaap:RestrictedStockMember bde:TwoThousandFifteenStockIncentivePlanMember bde:VestingThresholdOneMember 2023-03-14 0000913277 2023-01-01 2023-03-31 0000913277 2022-01-01 2022-03-31 0000913277 2023-03-31 0000913277 2022-12-31 bde:segment iso4217:EUR iso4217:CAD bde:item xbrli:shares xbrli:pure iso4217:USD xbrli:shares iso4217:USD

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended: March 31, 2023

or

¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _________ to _________

Commission File Number: 001-34767

CLARUS CORPORATION

(Exact name of registrant as specified in its charter)

Delaware | 58-1972600
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number)

2084 East 3900 South Salt Lake City, Utah |  | 84124
(Address of principal executive offices) |  | (Zip code)

(801) 278-5552
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol | Name of each exchange on which registered
Common Stock, par value $.0001 per share | CLAR | NASDAQ Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ¨ |  | Non-accelerated filer | ¨
Accelerated filer | x |  | Smaller reporting company | ¨
|  |  | Emerging growth company | ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of April 26, 2023, there were 37,190,302 shares of common stock, par value $0.0001, outstanding.

INDEX

CLARUS CORPORATION

PART I | FINANCIAL INFORMATION | Page
Item 1. | Financial Statements (Unaudited) |
| Condensed Consolidated Balance Sheets – March 31, 2023 and December 31, 2022 | 3
| Condensed Consolidated Statements of Comprehensive Income – Three months ended March 31, 2023 and 2022 | 4
| Condensed Consolidated Statements of Cash Flows – Three months ended March 31, 2023 and 2022 | 5
| Condensed Consolidated Statements of Stockholders’ Equity – Three months ended March 31, 2023 and 2022 | 6
| Notes to Condensed Consolidated Financial Statements | 7
Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 21
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 29
Item 4. | Controls and Procedures | 29
PART II | OTHER INFORMATION |
Item 1. | Legal Proceedings | 30
Item 1A. | Risk Factors | 30
Item 6. | Exhibits | 31
Signature Page |  | 32

2

PART I. FINANCIAL INFORMATION

I TEM 1. FINANCIAL STATEMENTS

CLARUS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands, except per share amounts)
| March 31, 2023 |  | December 31, 2022
Assets |  |  |  |  |
Current assets |  |  |  |  |
Cash | $ | 10,310 |  | $ | 12,061
Accounts receivable, less allowance for |  |  |  |  |
credit losses of $1,437 and $1,211 |  | 68,230 |  |  | 66,553
Inventories |  | 145,756 |  |  | 147,072
Prepaid and other current assets |  | 9,845 |  |  | 9,899
Income tax receivable |  | 3,209 |  |  | 3,034
Total current assets |  | 237,350 |  |  | 238,619
Property and equipment, net |  | 42,197 |  |  | 43,010
Other intangible assets, net |  | 51,482 |  |  | 55,255
Indefinite-lived intangible assets |  | 82,444 |  |  | 82,901
Goodwill |  | 62,704 |  |  | 62,993
Deferred income taxes |  | 18,168 |  |  | 17,912
Other long-term assets |  | 20,414 |  |  | 17,455
Total assets | $ | 514,759 |  | $ | 518,145
Liabilities and Stockholders' Equity |  |  |  |  |
Current liabilities |  |  |  |  |
Accounts payable | $ | 25,252 |  | $ | 27,052
Accrued liabilities |  | 22,125 |  |  | 25,170
Income tax payable |  | 684 |  |  | 421
Current portion of long-term debt |  | 12,562 |  |  | 11,952
Total current liabilities |  | 60,623 |  |  | 64,595
Long-term debt, net |  | 124,444 |  |  | 127,082
Deferred income taxes |  | 18,226 |  |  | 18,506
Other long-term liabilities |  | 18,574 |  |  | 15,854
Total liabilities |  | 221,867 |  |  | 226,037
Stockholders' Equity |  |  |  |  |
Preferred stock, $0.0001 par value per share; 5,000 |  |  |  |  |
shares authorized; none issued |  | - |  |  | -
Common stock, $0.0001 par value per share; 100,000 shares authorized; |  |  |  |  |
41,791 and 41,637 issued and 37,190 and 37,048 outstanding, respectively |  | 4 |  |  | 4
Additional paid in capital |  | 680,673 |  |  | 679,339
Accumulated deficit |  | (336,175) |  |  | (336,843)
Treasury stock, at cost |  | (32,825) |  |  | (32,707)
Accumulated other comprehensive loss |  | (18,785) |  |  | (17,685)
Total stockholders' equity |  | 292,892 |  |  | 292,108
Total liabilities and stockholders' equity | $ | 514,759 |  | $ | 518,145
See accompanying notes to condensed consolidated financial statements.

‎

3

CLARUS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
(In thousands, except per share amounts)
| Three Months Ended
| March 31, 2023 |  | March 31, 2022
Sales |  |  |  |  |
Domestic sales | $ | 44,916 |  | $ | 62,307
International sales |  | 52,468 |  |  | 50,969
Total sales |  | 97,384 |  |  | 113,276
Cost of goods sold |  | 61,363 |  |  | 69,024
Gross profit |  | 36,021 |  |  | 44,252
Operating expenses |  |  |  |  |
Selling, general and administrative |  | 32,819 |  |  | 34,175
Transaction costs |  | 74 |  |  | 1,201
Contingent consideration (benefit) expense |  | (1,565) |  |  | 763
Total operating expenses |  | 31,328 |  |  | 36,139
Operating income |  | 4,693 |  |  | 8,113
Other income (expense) |  |  |  |  |
Interest expense, net |  | (2,746) |  |  | (1,116)
Other, net |  | 85 |  |  | (67)
Total other expense, net |  | (2,661) |  |  | (1,183)
Income before income tax |  | 2,032 |  |  | 6,930
Income tax expense |  | 434 |  |  | 1,621
Net income |  | 1,598 |  |  | 5,309
Other comprehensive (loss) income, net of tax: |  |  |  |  |
Foreign currency translation adjustment |  | (1,021) |  |  | 6,077
Unrealized (loss) gain on hedging activities |  | (79) |  |  | 86
Other comprehensive (loss) income |  | (1,100) |  |  | 6,163
Comprehensive income | $ | 498 |  | $ | 11,472
Net income per share: |  |  |  |  |
Basic | $ | 0.04 |  | $ | 0.14
Diluted |  | 0.04 |  |  | 0.13
Weighted average shares outstanding: |  |  |  |  |
Basic |  | 37,137 |  |  | 37,161
Diluted |  | 38,109 |  |  | 39,802
See accompanying notes to condensed consolidated financial statements. |  |  |  |  |

‎

4

CLARUS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
|  | Three Months Ended
|  | March 31, 2023 |  | March 31, 2022
| Cash Flows From Operating Activities: |  |  |  |  |
| Net income | $ | 1,598 |  | $ | 5,309
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: |  |  |  |  |
| Depreciation of property and equipment |  | 1,791 |  |  | 1,832
| Amortization of other intangible assets |  | 3,276 |  |  | 4,120
| Amortization of debt issuance costs |  | 232 |  |  | 170
| Loss on disposition of property and equipment |  | 5 |  |  | 9
| Noncash lease expense |  | 690 |  |  | 694
| Contingent consideration (benefit) expense |  | (1,565) |  |  | 754
| Stock-based compensation |  | 1,334 |  |  | 3,367
| Deferred income taxes |  | (105) |  |  | 524
| Changes in operating assets and liabilities: |  |  |  |  |
| Accounts receivable |  | (2,797) |  |  | 437
| Inventories |  | 1,341 |  |  | (23,137)
| Prepaid and other assets |  | (153) |  |  | (856)
| Accounts payable |  | 90 |  |  | (2,101)
| Accrued liabilities |  | (2,612) |  |  | 820
| Income taxes |  | 74 |  |  | (2,737)
| Net cash provided by (used in) operating activities |  | 3,199 |  |  | (10,795)
| Cash Flows From Investing Activities: |  |  |  |  |
| Proceeds from disposition of property and equipment |  | 88 |  |  | -
| Purchases of property and equipment |  | (1,471) |  |  | (1,900)
| Net cash used in investing activities |  | (1,383) |  |  | (1,900)
| Cash Flows From Financing Activities: |  |  |  |  |
| Proceeds from revolving credit facilities |  | 11,731 |  |  | 25,670
| Repayments on revolving credit facilities |  | (12,153) |  |  | (13,689)
| Repayments on term loans |  | (1,668) |  |  | (1,613)
| Purchase of treasury stock |  | (118) |  |  | (1,097)
| Proceeds from exercise of options |  | - |  |  | 126
| Cash dividends paid |  | (930) |  |  | (930)
| Net cash (used in) provided by financing activities |  | (3,138) |  |  | 8,467
| Effect of foreign exchange rates on cash |  | (429) |  |  | 1,214
| Change in cash |  | (1,751) |  |  | (3,014)
| Cash, beginning of year |  | 12,061 |  |  | 19,465
| Cash, end of period | $ | 10,310 |  | $ | 16,451
| Supplemental Disclosure of Cash Flow Information: |  |  |  |  |
| Cash paid for income taxes | $ | 350 |  | $ | 3,844
| Cash paid for interest | $ | 2,586 |  | $ | 926
| Supplemental Disclosures of Non-Cash Investing and Financing Activities: |  |  |  |  |
| Property and equipment purchased with accounts payable | $ | 202 |  | $ | 425
| Lease liabilities arising from obtaining right of use assets | $ | 3,941 |  | $ | 1,164
See accompanying notes to condensed consolidated financial statements.

‎

5

CLARUS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited)
(In thousands, except per share amounts)

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Accumulated |  |  |
|  |  |  |  |  |  | Additional |  |  |  |  |  |  |  |  |  |  | Other |  | Total
| Common Stock |  | Paid-In |  | Accumulated |  | Treasury Stock |  | Comprehensive |  | Stockholders'
| Shares |  | Amount |  | Capital |  | Deficit |  | Shares |  | Amount |  | Income (Loss) |  | Equity
Balance, December 31, 2021 |  | 41,105 |  | $ | 4 |  | $ | 662,996 |  | $ | (263,342) |  |  | (4,011) |  | $ | (24,440) |  | $ | (5,050) |  | $ | 370,168
Net income |  | - |  |  | - |  |  | - |  |  | 5,309 |  |  | - |  |  | - |  |  | - |  |  | 5,309
Other comprehensive income |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 6,163 |  |  | 6,163
Cash dividends ($0.025 per share) |  | - |  |  | - |  |  | - |  |  | (930) |  |  | - |  |  | - |  |  | - |  |  | (930)
Purchase of treasury stock |  | - |  |  | - |  |  | - |  |  | - |  |  | (51) |  |  | (1,097) |  |  | - |  |  | (1,097)
Stock-based compensation expense |  | - |  |  | - |  |  | 3,367 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 3,367
Proceeds from exercise of options |  | 167 |  |  | - |  |  | 126 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 126
Balance, March 31, 2022 |  | 41,272 |  | $ | 4 |  | $ | 666,489 |  | $ | (258,963) |  |  | (4,062) |  | $ | (25,537) |  | $ | 1,113 |  | $ | 383,106
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Accumulated |  |  |
|  |  |  |  |  |  | Additional |  |  |  |  |  |  |  |  |  |  | Other |  | Total
| Common Stock |  | Paid-In |  | Accumulated |  | Treasury Stock |  | Comprehensive |  | Stockholders'
| Shares |  | Amount |  | Capital |  | Deficit |  | Shares |  | Amount |  | Loss |  | Equity
Balance, December 31, 2022 |  | 41,637 |  | $ | 4 |  | $ | 679,339 |  | $ | (336,843) |  |  | (4,589) |  | $ | (32,707) |  | $ | (17,685) |  | $ | 292,108
Net income |  | - |  |  | - |  |  | - |  |  | 1,598 |  |  | - |  |  | - |  |  | - |  |  | 1,598
Other comprehensive loss |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | (1,100) |  |  | (1,100)
Cash dividends ($0.025 per share) |  | - |  |  | - |  |  | - |  |  | (930) |  |  | - |  |  | - |  |  | - |  |  | (930)
Purchase of treasury stock |  | - |  |  | - |  |  | - |  |  | - |  |  | (12) |  |  | (118) |  |  | - |  |  | (118)
Stock-based compensation expense |  | - |  |  | - |  |  | 1,334 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 1,334
Proceeds from exercise of options |  | 154 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | -
Balance, March 31, 2023 |  | 41,791 |  | $ | 4 |  | $ | 680,673 |  | $ | (336,175) |  |  | (4,601) |  | $ | (32,825) |  | $ | (18,785) |  | $ | 292,892
See accompanying notes to condensed consolidated financial statements.

6

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(in thousands, except per share amounts)

NOT E 1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The accompanying unaudited condensed consolidated financial statements of Clarus Corporation and subsidiaries (which may be referred to as the “Company,” “Clarus,” “we,” “us” or “our”) as of March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022, have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), instructions to the Quarterly Report on Form 10-Q, and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments, except otherwise disclosed) necessary for a fair presentation of the unaudited condensed consolidated financial statements have been included. The results for the three months ended March 31, 2023 are not necessarily indicative of the results to be obtained for the year ending December 31, 2023. These interim financial statements should be read in conjunction with the Company’s audited consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission (the “SEC”) on February 27, 2023.

Nature of Business

Headquartered in Salt Lake City, Utah, we are a global leading designer, developer, manufacturer and distributor of best-in-class outdoor equipment and lifestyle products focused on the outdoor and consumer enthusiast markets. Our mission is to identify, acquire and grow outdoor “super fan” brands through our unique “innovate and accelerate” strategy. We define a “super fan” brand as a brand that creates the world’s pre-eminent, performance-defining product that the best-in-class user cannot live without. Each of our brands has a long history of continuous product innovation for core and everyday users alike. The Company’s products are principally sold globally under the Black Diamond®, Sierra®, Barnes®, Rhino-Rack® and MAXTRAX® brand names through outdoor specialty and online retailers, our own websites, distributors and original equipment manufacturers.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The more significant estimates relate to the fair value of net assets acquired in business combinations, excess or obsolete inventory, allowance for credit losses, contingent consideration liabilities, and valuation of deferred tax assets, long-lived assets, goodwill and indefinite-lived intangible assets, and other intangible assets. We base our estimates on historical experience, projected future cash flows, and other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates.

NOTE 2. INVENTORIES

Inventories, as of March 31, 2023 and December 31, 2022, were as follows:

| March 31, 2023 |  | December 31, 2022
Finished goods | $ | 107,152 |  | $ | 107,453
Work-in-process |  | 9,822 |  |  | 8,719
Raw materials and supplies |  | 28,782 |  |  | 30,900
| $ | 145,756 |  | $ | 147,072

7

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

NOTE 3. PROPERTY AND EQUIPMENT

Property and equipment, net, as of March 31, 2023, and December 31, 2022, were as follows:

| March 31, 2023 |  | December 31, 2022
Land | $ | 4,160 |  | $ | 4,160
Building and improvements |  | 17,369 |  |  | 17,357
Furniture and fixtures |  | 7,355 |  |  | 7,384
Computer hardware and software |  | 8,615 |  |  | 8,498
Machinery and equipment |  | 37,701 |  |  | 37,054
Construction in progress |  | 5,165 |  |  | 5,028
|  | 80,365 |  |  | 79,481
Less accumulated depreciation |  | (38,168) |  |  | (36,471)
| $ | 42,197 |  | $ | 43,010

Depreciation expense for the three months ended March 31, 2023 and 2022 was $1,791 and $1,832, respectively.

NOTE 4. GOODWILL AND INTANGIBLE ASSETS

Goodwill

The following table summarizes the balances in goodwill by segment:

| Outdoor |  | Precision Sport |  | Adventure |  | Total
Goodwill | $ | 29,507 |  | $ | 26,715 |  | $ | 88,349 |  | $ | 144,571
Accumulated goodwill impairment losses |  | (29,507) |  |  | - |  |  | (52,071) |  |  | (81,578)
Balance at December 31, 2022 |  | - |  |  | 26,715 |  |  | 36,278 |  |  | 62,993
Impact of foreign currency exchange rates |  | - |  |  | - |  |  | (289) |  |  | (289)
Balance at March 31, 2023 | $ | - |  | $ | 26,715 |  | $ | 35,989 |  | $ | 62,704

Indefinite-Lived Intangible Assets

The following table summarizes the changes in indefinite-lived intangible assets:

Balance at December 31, 2022 | $ | 82,901
Impact of foreign currency exchange rates |  | (457)
Balance at March 31, 2023 | $ | 82,444

8

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

Trademarks classified as indefinite-lived intangible assets by brand as of March 31, 2023 and December 31, 2022, were as follows:

| March 31, 2023 |  | December 31, 2022
Black Diamond | $ | 19,600 |  | $ | 19,600
PIEPS |  | 3,036 |  |  | 2,986
Sierra |  | 18,900 |  |  | 18,900
Barnes |  | 5,600 |  |  | 5,600
Rhino-Rack |  | 25,379 |  |  | 25,744
MAXTRAX |  | 9,929 |  |  | 10,071
| $ | 82,444 |  | $ | 82,901

Other Intangible Assets, net

The following table summarizes the changes in gross other intangible assets:

Gross balance at December 31, 2022 | $ | 100,889
Impact of foreign currency exchange rates |  | (697)
Gross balance at March 31, 2023 | $ | 100,192

Other intangible assets, net of amortization as of March 31, 2023 and December 31, 2022, were as follows:

| March 31, 2023
| Gross |  | Accumulated Amortization |  | Net |  | Weighted Average Useful Life
Intangibles subject to amortization |  |  |  |  |  |  |  |  |  |  |
Customer relationships | $ | 76,852 |  | $ | (36,924) |  | $ | 39,928 |  |  | 13.8 years
Product technologies |  | 21,130 |  |  | (9,974) |  |  | 11,156 |  |  | 10.2 years
Tradename / trademark |  | 1,263 |  |  | (865) |  |  | 398 |  |  | 9.4 years
Core technologies |  | 947 |  |  | (947) |  |  | - |  |  | 10.0 years
| $ | 100,192 |  | $ | (48,710) |  | $ | 51,482 |  |  | 13.0 years
| December 31, 2022
| Gross |  | Accumulated Amortization |  | Net |  | Weighted Average Useful Life
Customer relationships | $ | 77,370 |  | $ | (34,653) |  | $ | 42,717 |  |  | 13.8 years
Product technologies |  | 21,309 |  |  | (9,207) |  |  | 12,102 |  |  | 10.2 years
Tradename / trademark |  | 1,263 |  |  | (827) |  |  | 436 |  |  | 9.4 years
Core technologies |  | 947 |  |  | (947) |  |  | - |  |  | 10.0 years
| $ | 100,889 |  | $ | (45,634) |  | $ | 55,255 |  |  | 13.0 years

9

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

Amortization expense for the three months ended March 31, 2023 and 2022, was $3,276 and $4,120, respectively. Future amortization expense for other intangible assets as of March 31, 2023 is as follows:

Years Ending December 31, | Amortization Expense
2023 (excluding the three months ended March 31, 2023) | $ | 9,427
2024 |  | 10,654
2025 |  | 8,622
2026 |  | 6,619
2027 |  | 4,837
2028 |  | 3,451
Thereafter |  | 7,872
| $ | 51,482

NOTE 5. ACCRUED LIABILITIES AND OTHER LONG-TERM LIABILITIES

Accrued liabilities as of March 31, 2023 and December 31, 2022, were as follows:

| March 31, 2023 |  | December 31, 2022
Accrued payroll and related items | $ | 4,626 |  | $ | 5,363
Accrued bonus |  | 1,581 |  |  | 1,006
Designated forward exchange contracts |  | 207 |  |  | -
Accrued warranty |  | 1,371 |  |  | 1,465
Current lease liabilities |  | 3,231 |  |  | 2,836
Accrued commissions |  | 733 |  |  | 343
Contingent consideration liabilities |  | - |  |  | 1,595
Accrued excise tax |  | 764 |  |  | 977
Other |  | 9,612 |  |  | 11,585
| $ | 22,125 |  | $ | 25,170

Other long-term liabilities as of March 31, 2023 and December 31, 2022, were as follows:

| March 31, 2023 |  | December 31, 2022
Long-term lease liability | $ | 15,629 |  | $ | 12,825
Deferred stock consideration for business acquisition |  | 2,096 |  |  | 2,127
Other |  | 849 |  |  | 902
| $ | 18,574 |  | $ | 15,854

10

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

NOTE 6. LONG-TERM DEBT

Long-term debt as of March 31, 2023 and December 31, 2022, was as follows:

| March 31, 2023 |  | December 31, 2022
Revolving credit facility (a) | $ | 18,538 |  | $ | 18,049
Other debt (b) |  | 126 |  |  | 1,134
Term loan (c) |  | 118,750 |  |  | 120,311
Debt issuance costs |  | (408) |  |  | (460)
|  | 137,006 |  |  | 139,034
Less current portion |  | (12,562) |  |  | (11,952)
| $ | 124,444 |  | $ | 127,082

On April 18, 2022 (the “Effective Date”), the Company and certain of its direct and indirect subsidiaries entered into an Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent and the lenders party thereto (the “Restated Credit Agreement”).

The Restated Credit Agreement provides for borrowings of up to $300,000 under a secured revolving credit facility (the “Revolving Loans”) (including up to $5,000 for letters of credit), and borrowings of up to $125,000 under a secured term loan facility (the “Term Loans”). The Restated Credit Agreement also permits the Company, subject to certain requirements, to arrange with lenders for an aggregate of up to $175,000 of additional revolving and/or term loan commitments (both of which are currently uncommitted), for potential aggregate revolving and term loan commitments under the Restated Credit Agreement of up to $600,000. The Restated Credit Agreement matures on April 18, 2027 (the “Maturity Date”), at which time the revolving commitments thereunder will terminate and all outstanding Revolving Loans and Term Loans, together with all accrued and unpaid interest thereon, must be repaid.

All obligations under the Restated Credit Agreement are secured by our subsidiary equity interests, as well as accounts receivable, inventory, intellectual property and certain other assets owned by the Company. The Restated Credit Agreement contains restrictions on the Company’s ability to pay dividends or make distributions or other restricted payments if certain conditions in the Restated Credit Agreement are not fulfilled. The Restated Credit Agreement also includes other customary affirmative and negative covenants, including financial covenants relating to the Company’s consolidated total leverage ratio and fixed charge coverage ratio. The Company was in compliance with the debt covenants set forth in the Credit Agreement as of March 31, 2023.

(a)As of March 31, 2023, the Company had drawn $18,538 on the revolving loan, with a maturity date of April 18, 2027. Approximately $61,000 in additional funds were available to borrow on the revolving loan at March 31, 2023, while maintaining compliance with the consolidated total leverage ratio per the Restated Credit Agreement of 3.75 to 1. The Company pays interest monthly on any borrowings on the Restated Credit Agreement. As of March 31, 2023 and December 31, 2022, the rates were approximately 6.8% and 6.3%, respectively.

(b)Foreign subsidiaries of the Company have a revolving credit facility and term debt with financial institutions which mature between April 26, 2023 and August 8, 2024. The foreign subsidiaries pay interest monthly on any borrowings on the credit facilities as well as monthly payments on the term debt. As of March 31, 2023, the interest rates ranged between approximately 3.2% and 4.0% and as of December 31, 2022, the interest rates ranged between approximately 1.3% and 4.0%. The credit facilities are secured by certain assets of the foreign subsidiaries. The revolving credit facility was settled and closed as of March 31, 2023 and had no amounts outstanding.

(c)The Company is required to repay the term loan through quarterly payments of $1,563 each beginning with June 30, 2022, increasing to $3,125 each beginning with June 30, 2023, and any remaining obligations will be repaid in full on the maturity date of the Restated Credit Agreement of April 18, 2027. The Company pays interest monthly on any borrowings on the Restated Credit Agreement. As of March 31, 2023 and December 31, 2022, the rates were approximately 6.8% and 6.3%, respectively.

11

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

NOTE 7. DERIVATIVE FINANCIAL INSTRUMENTS

The Company’s primary exchange rate risk management objective is to mitigate the uncertainty of anticipated cash flows attributable to changes in foreign currency exchange rates. The Company primarily focuses on mitigating changes in cash flows resulting from sales denominated in currencies other than the U.S. dollar. The Company manages this risk primarily by using currency forward and option contracts. If the anticipated transactions are deemed probable, the resulting relationships are formally designated as cash flow hedges. The Company accounts for these contracts as cash flow hedges and tests effectiveness by determining whether changes in the expected cash flow of the derivative offset, within a range, changes in the expected cash flow of the hedged item.

At March 31, 2023, the Company’s derivative contracts had remaining maturities of less than one year. The counterparties to these transactions had both long-term and short-term investment grade credit ratings. The maximum net exposure of the Company’s credit risk to the counterparties is generally limited to the aggregate unrealized loss of $207 on all contracts as March 31, 2023. The Company’s exposure of counterparty credit risk is limited to the aggregate unrealized gain of all contracts with that counterparty. At March 31, 2023, there was no such exposure to the counterparties. The Company’s derivative counterparties have strong credit ratings and as a result, the Company does not require collateral to facilitate transactions.

The Company held the following contracts designated as hedging instruments as of March 31, 2023 and December 31, 2022:

| March 31, 2023
| Notional |  | Latest
| Amount |  | Maturity
Foreign exchange contracts - Euros | € 20,871 |  | February 2024

| December 31, 2022
| Notional |  | Latest
| Amount |  | Maturity
Foreign exchange contracts - Canadian Dollars | $2,807 |  | February 2023
Foreign exchange contracts - Euros | € 20,760 |  | February 2024

For contracts that qualify as effective hedge instruments, the effective portion of gains and losses resulting from changes in fair value of the instruments are included in accumulated other comprehensive loss and reclassified to sales in the period the underlying hedged transaction is recognized in earnings. Gains (losses) of $(16) and $253 were reclassified to sales during the three months ended March 31, 2023 and 2022, respectively.

The following table presents the balance sheet classification and fair value of derivative instruments as of March 31, 2023 and December 31, 2022:

| Classification |  | March 31, 2023 |  | December 31, 2022
Derivative instruments in asset positions: |  |  |  |  |  |  |
Designated forward exchange contracts | Prepaid and other current assets |  | $ | - |  | $ | 357
Derivative instruments in liability positions: |  |  |  |  |  |  |
Designated forward exchange contracts | Accrued liabilities |  | $ | 207 |  | $ | -
Designated forward exchange contracts | Other long-term liabilities |  | $ | - |  | $ | 6

12

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

NOTE 8. ACCUMULATED OTHER COMPREHENSIVE LOSS

Accumulated other comprehensive loss (“AOCI”) primarily consists of foreign currency translation adjustments and changes in our forward foreign exchange contracts. The following table sets forth the changes in AOCI, net of tax, for the three months ended March 31, 2023:

| Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total
Balance as of December 31, 2022 | $ | (17,628) |  | $ | (57) |  | $ | (17,685)
Other comprehensive loss before reclassifications |  | (1,021) |  |  | (91) |  |  | (1,112)
Amounts reclassified from other comprehensive loss |  | - |  |  | 12 |  |  | 12
Net current period other comprehensive loss |  | (1,021) |  |  | (79) |  |  | (1,100)
Balance as of March 31, 2023 | $ | (18,649) |  | $ | (136) |  | $ | (18,785)

The following table sets forth the changes in AOCI, net of tax, for the three months ended March 31, 2022:

| Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total
Balance as of December 31, 2021 | $ | (5,241) |  | $ | 191 |  | $ | (5,050)
Other comprehensive income before reclassifications |  | 6,077 |  |  | 280 |  |  | 6,357
Amounts reclassified from other comprehensive income |  | - |  |  | (194) |  |  | (194)
Net current period other comprehensive income |  | 6,077 |  |  | 86 |  |  | 6,163
Balance as of March 31, 2022 | $ | 836 |  | $ | 277 |  | $ | 1,113

The effects on net income of amounts reclassified from unrealized gains (losses) on cash flow hedges for foreign exchange contracts for the three months ended March 31, 2023 and 2022, were as follows:

| Gains (losses) reclassified from AOCI to the Consolidated Statements of Comprehensive Income
Affected line item in the Consolidated | Three Months Ended
Statements of Comprehensive Income | March 31, 2023 |  | March 31, 2022
Foreign exchange contracts: |  |  |  |  |
Sales | $ | (16) |  | $ | 253
Less: Income tax (benefit) expense |  | (4) |  |  | 59
Amount reclassified, net of tax | $ | (12) |  | $ | 194
Total reclassifications from AOCI | $ | (12) |  | $ | 194

13

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

NOTE 9. FAIR VALUE MEASUREMENTS

We measure certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, under a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

Level 1 - inputs to the valuation methodology are quoted market prices for identical assets or liabilities in active markets.

Level 2 - inputs to the valuation methodology include quoted prices in markets that are not active or model inputs that are

observable either directly or indirectly for substantially the full term of the asset or liability.

Level 3 - inputs to the valuation methodology are based on prices or valuation techniques that are unobservable.

Items Measured at Fair Value on a Recurring Basis

Assets and liabilities measured at fair value on a recurring basis at March 31, 2023 and December 31, 2022 were as follows:

| March 31, 2023
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |  |  |  |  |
Designated forward exchange contracts | $ | - |  | $ | - |  | $ | - |  | $ | -
| $ | - |  | $ | - |  | $ | - |  | $ | -
Liabilities |  |  |  |  |  |  |  |  |  |  |
Designated forward exchange contracts | $ | - |  | $ | 207 |  | $ | - |  | $ | 207
| $ | - |  | $ | 207 |  | $ | - |  | $ | 207
| December 31, 2022
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |  |  |  |  |
Designated forward exchange contracts | $ | - |  | $ | 357 |  | $ | - |  | $ | 357
| $ | - |  | $ | 357 |  | $ | - |  | $ | 357
Liabilities |  |  |  |  |  |  |  |  |  |  |
Designated forward exchange contracts | $ | - |  | $ | 6 |  | $ | - |  | $ | 6
Contingent consideration liabilities | $ | - |  | $ | - |  | $ | 1,595 |  | $ | 1,595
| $ | - |  | $ | 6 |  | $ | 1,595 |  | $ | 1,601

Derivative financial instruments are recorded at fair value based on current market pricing models. No nonrecurring fair value measurements existed at March 31, 2023 and December 31, 2022.

The Company estimated the initial fair value of the contingent consideration liabilities primarily using a series of call options. Significant unobservable inputs used in the valuation included discount rates ranging from 4.8% to 8.0%. Contingent consideration liabilities are subsequently remeasured at the estimated fair value at the end of each reporting period using financial projections of the acquired company, such as sales-based milestones and estimated probabilities of achievement, with the change in fair value recognized in contingent consideration benefit in the accompanying consolidated statements of comprehensive income for such period. We measure the initial liability and remeasure the liability on a recurring basis using Level 3 inputs as defined under authoritative guidance for fair value measurements.

14

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

The following table summarizes the changes in contingent consideration liabilities:

| MAXTRAX
Balance at December 31, 2022 | $ | 1,595
Fair value adjustments |  | (1,565)
Contingent consideration payments |  | -
Impact of foreign currency exchange rates |  | (30)
Balance at March 31, 2023 | $ | -

As the contingent consideration liabilities are remeasured to fair value each reporting period, significant increases or decreases in projected sales, discount rates or the time until payment is made could have resulted in a significantly lower or higher fair value measurement. Our determination of fair value of the contingent consideration liabilities could change in future periods based on our ongoing evaluation of these significant unobservable inputs. As of March 31, 2023, the net sales threshold required for the payment of the MAXTRAX contingent consideration is not expected to be met during the measurement period ended June 30, 2023.

NOTE 10. STOCKHOLDERS’ EQUITY

On August 6, 2018, the Company announced that its Board of Directors approved the initiation of a quarterly cash dividend program of $0.025 per share of the Company’s common stock (the “Quarterly Cash Dividend”) or $0.10 per share on an annualized basis. The declaration and payment of future Quarterly Cash Dividends is subject to the discretion of and approval of the Company’s Board of Directors. On April 28, 2023, the Company announced that its Board of Directors approved the payment on May 19, 2023 of the Quarterly Cash Dividend of $0.025 to the record holders of shares of the Company’s common stock as of the close of business on May 8, 2023.

NOTE 11. EARNINGS PER SHARE

Basic earnings per share is computed by dividing earnings by the weighted average number of common shares outstanding during each period. Diluted earnings per share is computed by dividing earnings by the total of the weighted average number of shares of common stock outstanding during each period, plus the effect of dilutive outstanding stock options and unvested restricted stock grants. Potentially dilutive securities are excluded from the computation of diluted earnings per share if their effect is anti-dilutive to the loss from continuing operations.

The following table is a reconciliation of basic and diluted shares of common stock outstanding used in the calculation of earnings per share:

| Three Months Ended
| March 31, 2023 |  | March 31, 2022
Weighted average shares outstanding - basic |  | 37,137 |  |  | 37,161
Effect of dilutive stock awards |  | 750 |  |  | 2,435
Effect of dilutive deferred stock consideration for business acquisition |  | 222 |  |  | 206
Weighted average shares outstanding - diluted |  | 38,109 |  |  | 39,802
Net income per share: |  |  |  |  |
Basic | $ | 0.04 |  | $ | 0.14
Diluted |  | 0.04 |  |  | 0.13

For the three months ended March 31, 2023 and 2022, equity awards of 3,713 and 1,329, respectively, were excluded from the calculation of earnings per share for these periods as they were anti-dilutive.

15

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

NOTE 12. STOCK-BASED COMPENSATION PLAN

Under the Company’s current 2015 Stock Incentive Plan (the “2015 Plan”), the Company’s Board of Directors has flexibility to determine the type and amount of awards to be granted to eligible participants, who must be employees, directors, officers or consultants of the Company or its subsidiaries. The 2015 Plan allows for grants of incentive stock options, nonqualified stock options, restricted stock awards, stock appreciation rights, and restricted units. The aggregate number of shares of common stock that may be granted through awards under the 2015 Plan to any employee in any calendar year may not exceed 500 shares. The 2015 Plan will continue in effect until December 2025 unless terminated sooner.

During the three months ended March 31, 2023, the Company did not issue any stock options under the 2015 Plan to employees of the Company.

Market Condition Restricted Shares Granted:

On March 14, 2023, the Company awarded the Executive Chairman 500 restricted shares under the 2015 Plan, of which 250 and 250 shares will vest if, on or before March 14, 2033, the Fair Market Value (as defined in the Plan) of the Company’s common stock shall have equaled or exceeded $15.00 and $18.00 per share for twenty consecutive trading days, respectively. As the vesting terms of the restricted shares include a market condition, the fair value of the restricted stock was estimated as of the date of grant using the Monte-Carlo pricing model with the following assumptions:

|  | March 14, 2023
Number issued |  | 500
Vesting period |  | $15.00 - $18.00 stock price target
Grant price (per share) |  | $9.60
Dividend yield |  | 1.04%
Expected volatility |  | 45.2%
Risk-free interest rate |  | 3.64%
Expected term (years) |  | 2.56 - 3.22
Weighted average fair value (per share) |  | $7.84 - $8.34

Using these assumptions, the grant date fair value of the restricted stock awards was approximately $4,046 and the expected term was between 2.56 and 3.22 years.

The total non-cash stock compensation expense related to restricted stock, stock options and stock awards recorded by the Company for the three months ended March 31, 2023 and 2022 was $1,334 and $3,367, respectively. For the three months ended March 31, 2023 and 2022, the majority of stock-based compensation costs were classified as selling, general and administrative expenses.

As of March 31, 2023, there were 587 unvested stock options and unrecognized compensation cost of $2,797 related to unvested stock options, as well as 1,717 unvested restricted stock awards and unrecognized compensation costs of $10,836 related to unvested restricted stock awards.

NOTE 13. COMMITMENTS AND CONTINGENCIES

As a consumer goods manufacturer and distributor, the Company faces the risk of product liability and related lawsuits involving claims for substantial money damages, product recall actions and higher than anticipated rates of warranty returns or other returns of goods. The Company is therefore vulnerable to various personal injury and property damage lawsuits relating to its products and incidental to its business.

The Company is involved in various legal disputes and other legal proceedings that arise from time to time in the ordinary course of business. Anticipated costs related to l itigation matters are accrued when it is both probable that a liability has been incurred and the amount can be reasonably estimated. Based on currently available information, the Company does not believe that it is reasonably possible that the disposition of any of the legal disputes the Company or its subsidiaries is currently involved in will have a material adverse effect upon the Company’s consolidated financial condition, results of operations or cash flows. There is a reasonable possibility of loss from contingencies in excess of the amounts accrued by the Company in the accompanying condensed consolidated balance sheets; however, the actual amounts of such possible losses cannot currently be reasonably estimated by the Company at this time. It is possible that, as additional information becomes available, the impact on the Company could have a different effect.

16

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

NOTE 14. INCOME TAXES

The Company’s U.S. federal statutory tax rate of 21% and its foreign operations have statutory tax rates of approximately 24% in Austria, 28% in New Zealand, and 30% in Australia.

The difference between the Company’s estimated effective tax rates of 21.4% for the three months ended March 31, 2023, and the U.S. federal statutory tax rate of 21% was primarily due to the impact of stock compensation, research and experimentation expenditures and credits, and discrete stock option windfall benefits in the first quarter of 2023.

As of December 31, 2022, the Company’s gross deferred tax asset was $32,972. The Company has recorded a valuation allowance of $3,323, resulting in a net deferred tax asset of $29,649, before deferred tax liabilities of $30,243. The Company has provided a valuation allowance against a portion of the deferred tax assets as of March 31, 2023 and December 31, 2022, because the ultimate realization of those assets did not meet the more-likely-than-not criteria. The majority of the Company’s deferred tax assets consist of net operating loss carryforwards (“NOLs”) for federal tax purposes. If a change in control were to occur, these could be limited under Section 382 of the Internal Revenue Code of 1986 (“Code”), as amended.

In assessing the realizability of deferred income tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible and net operating loss and credit carryforwards expire. The estimates and judgments associated with the Company’s valuation allowance on deferred tax assets are considered critical due to the amount of deferred tax assets recorded by the Company on its consolidated balance sheet and the judgment required in determining the Company’s future taxable income. The need for a valuation allowance is reassessed at each interim reporting period.

As of December 31, 2022, the Company had NOLs and research and experimentation credit for U.S. federal income tax purposes of $17,663 and $2,651, respectively. The Company believes its U.S. Federal NOLs will substantially offset its future U.S. Federal income taxes until expiration.

NOLs available to offset taxable income, subject to compliance with Section 382 of the Code, begin to expire based upon the following schedule:

Net Operating Loss Carryforward Expiration Dates
December 31, 2022
Expiration Dates December 31, |  | Net Operating Loss Amount
2023 |  | $ | 1,851
2024 |  |  | 3,566
2025 |  |  | 1,708
2026 and beyond |  |  | 10,538
Total |  | $ | 17,663

17

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

NOTE 15. SEGMENT INFORMATION

We operate our business structure within three segments. These segments are defined based on the internal financial reporting used by our chief operating decision maker to allocate resources and assess performance. Certain significant selling and general and administrative expenses are not allocated to the segments including non-cash stock compensation expense. Each segment is described below:

Our Outdoor segment, which includes Black Diamond Equipment, PIEPS, and SKINourishment, is a global leader in designing, manufacturing, and marketing innovative outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. Our Outdoor segment offers a broad range of products including: high-performance, activity-based apparel (such as shells, insulation, midlayers, pants and logowear); rock-climbing footwear and equipment (such as carabiners, protection devices, harnesses, belay devices, helmets, and ice-climbing gear); technical backpacks and high-end day packs; trekking poles; headlamps and lanterns; gloves and mittens; and skincare and other sport-enhancing products. We also offer advanced skis, ski poles, ski skins, and snow safety products, including avalanche airbag systems, avalanche transceivers, shovels, and probes.

Our Precision Sport segment, which includes Sierra and Barnes, includes two iconic American manufacturers of a wide range of high-performance bullets and ammunition for both rifles and pistols. These bullets are used for precision target shooting, hunting and military and law enforcement purposes.

Our Adventure segment, which includes Rhino-Rack and MAXTRAX, is a manufacturer of highly-engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and a growing presence in the United States.

As noted above, the Company has a wide variety of technical outdoor equipment and lifestyle products that are sold to a variety of customers in multiple end markets. While there are multiple products sold, the terms and nature of revenue recognition policy is similar for all segments.

18

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

Financial information for our segments, as well as revenue by geography, which the Company believes provides a meaningful depiction how the nature, timing and uncertainty of revenue are affected by economic factors, is as follows:

| Three Months Ended
| March 31, 2023 |  | March 31, 2022
Sales to external customers: |  |  |  |  |
Outdoor |  |  |  |  |
Domestic sales | $ | 21,565 |  | $ | 25,629
International sales |  | 31,210 |  |  | 25,893
Total Outdoor |  | 52,775 |  |  | 51,522
Precision Sport |  |  |  |  |
Domestic sales |  | 20,719 |  |  | 27,443
International sales |  | 6,387 |  |  | 5,675
Total Precision Sport |  | 27,106 |  |  | 33,118
Adventure |  |  |  |  |
Domestic sales |  | 2,632 |  |  | 9,235
International sales |  | 14,871 |  |  | 19,401
Total Adventure |  | 17,503 |  |  | 28,636
Total sales to external customers |  | 97,384 |  |  | 113,276
Segment operating income (loss): |  |  |  |  |
Outdoor |  | 1,490 |  |  | 1,888
Precision Sport |  | 7,225 |  |  | 11,780
Adventure |  | (1,148) |  |  | 2,124
Total segment operating income |  | 7,567 |  |  | 15,792
Transaction costs |  | (74) |  |  | (1,201)
Contingent consideration benefit (expense) |  | 1,565 |  |  | (763)
Corporate and other expenses |  | (4,280) |  |  | (5,782)
Interest expense, net |  | (2,746) |  |  | (1,116)
Income before income tax | $ | 2,032 |  | $ | 6,930

There were no intercompany sales between the Outdoor, Precision Sport, and Adventure segments for the periods presented.

Total assets by segment, as of March 31, 2023 and December 31, 2022, were as follows:

| March 31, 2023 |  | December 31, 2022
Outdoor | $ | 175,390 |  | $ | 175,820
Precision Sport |  | 143,000 |  |  | 144,224
Adventure |  | 178,485 |  |  | 181,867
Corporate |  | 17,884 |  |  | 16,234
| $ | 514,759 |  | $ | 518,145

19

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

Capital expenditures, depreciation and amortization by segment is as follows.

| Three Months Ended
| March 31, 2023 |  | March 31, 2022
Capital expenditures: |  |  |  |  |
Outdoor | $ | 323 |  | $ | 1,236
Precision Sport |  | 739 |  |  | 450
Adventure |  | 409 |  |  | 214
Total capital expenditures | $ | 1,471 |  | $ | 1,900
Depreciation: |  |  |  |  |
Outdoor | $ | 673 |  | $ | 817
Precision Sport |  | 852 |  |  | 781
Adventure |  | 266 |  |  | 234
Total depreciation | $ | 1,791 |  | $ | 1,832
Amortization: |  |  |  |  |
Outdoor | $ | 258 |  | $ | 255
Precision Sport |  | 508 |  |  | 692
Adventure |  | 2,510 |  |  | 3,173
Total amortization | $ | 3,276 |  | $ | 4,120

20

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

Please note that in this Quarterly Report on Form 10-Q Clarus Corporation (which may be referred to as the “Company,” “Clarus,” “we,” “our” or “us”) may use words such as “appears,” “anticipates,” “believes,” “plans,” “expects,” “intends,” “future” and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements.

Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this Quarterly Report on Form 10-Q include, but are not limited to, the overall level of consumer demand on our products; general economic conditions and other factors affecting consumer confidence, preferences, and behavior; disruption and volatility in the global currency, capital and credit markets; the financial strength of the Company’s customers; the Company’s ability to implement its business strategy; the ability of the Company to execute and integrate acquisitions; changes in governmental regulation, legislation or public opinion relating to the manufacture and sale of bullets and ammunition, and the possession and use of firearms and ammunition by our customers; the Company’s exposure to product liability or product warranty claims and other loss contingencies; disruptions and other impacts to the Company’s business, as a result of an outbreak of disease or similar public health threat, such as the COVID-19 global pandemic, and government actions and restrictive measures implemented in response; stability of the Company’s manufacturing facilities and suppliers, as well as consumer demand for our products, in light of disease epidemics and health-related concerns such as the COVID-19 global pandemic; the impact that global climate change trends may have on the Company and its suppliers and customers, increased focus on sustainability issues as a result of global climate change; regulatory or market responses to global climate change; the Company's ability to protect patents, trademarks and other intellectual property rights; any breaches of, or interruptions in, our information systems; the ability of our information technology systems or information security systems to operate effectively, including as a result of security breaches, viruses, hackers, malware, natural disasters, vendor business interruptions or other causes; our ability to properly maintain, protect, repair or upgrade our information technology systems or information security systems, or problems with our transitioning to upgraded or replacement systems; the impact of adverse publicity about the Company and/or its brands, including without limitation, through social media or in connection with brand damaging events and/or public perception; fluctuations in the price, availability and quality of raw materials and contracted products as well as foreign currency fluctuations; ongoing disruptions and delays in the shipping and transportation of our products due to port congestion, container ship availability and/or other logistical challenges; the impact of political unrest, natural disasters or other crises, terrorist acts, acts of war and/or military operations; our ability to utilize our net operating loss carryforwards; changes in tax laws and liabilities, tariffs, legal, regulatory, political and economic risks; the Company’s ability to maintain a quarterly dividend; and any material differences in the actual financial results of the Company’s past and future acquisitions, including, without limitation, its previous acquisition of Rhino-Rack as compared with expectations, including the impact of acquisitions and any recognition of impairment or other charges relating to any such acquisitions on the Company’s future earnings per share. More information on potential factors that could affect the Company’s financial results is included from time to time in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. All forward-looking statements included in this Quarterly Report on Form 10-Q are based upon information available to the Company as of the date of this Quarterly Report on Form 10-Q, and speak only as of the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q.

Overview

Headquartered in Salt Lake City, Utah, Clarus Corporation (which may be referred to as the “Company,” “Clarus,” “we,” “our” or “us”) is a global leading designer, developer, manufacturer and distributor of best-in-class outdoor equipment and lifestyle products focused on the outdoor and consumer enthusiast markets. Our mission is to identify, acquire and grow outdoor “super fan” brands through our unique “innovate and accelerate” strategy. We define a “super fan” brand as a brand that creates the world’s pre-eminent, performance-defining product that the best-in-class user cannot live without. Each of our brands has a long history of continuous product innovation for core and everyday users alike. The Company’s products are principally sold globally under the Black Diamond®, Sierra®, Barnes®, Rhino-Rack® and MAXTRAX® brand names through outdoor specialty and online retailers, our own websites, distributors and original equipment manufacturers. Our portfolio of iconic brands is well-positioned for sustainable, long-term growth underpinned by powerful industry trends across the outdoor and adventure sport end markets.

21

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

One of the key elements of our sustained financial performance is our persistent focus on brand building through product initiatives. Our iconic brands are rooted in performance-defining technologies that enable our customers to have their best days outdoors. We have a long history of technical innovation and product development, backed by an extensive patent portfolio that continues to evolve and advance our markets. We currently employ approximately 120 engineers across the portfolio, focusing on enhancing our customers’ performance in the most critical moments. Our commitment to quality, rigorous safety, and ultimately best-in-class design is evidenced by outstanding industry recognition, as we have received numerous product awards across our portfolio of super fan brands.

Each of our brands represents a unique customer value proposition. Supported by six decades of proven innovation, Black Diamond is an established global leader in high-performance, activity-based climbing, skiing, and technical mountain sports equipment. The brand is synonymous with premium performance, safety and reliability. Our Sierra and Barnes brands have been leading specialty manufacturers of bullets and ammunition for over 50 years. Since 1947, Sierra has been dedicated to manufacturing the highest-quality, most accurate bullets in the world for hunting and sport shooting enthusiasts. Barnes traces its history back to 1932, and since 1989 has manufactured technologically-advanced, lead-free bullets and premium ammunition for hunters, range shooters, military and law enforcement professionals. Founded in 1992, our Rhino-Rack brand is a globally-recognized designer and distributor of highly-engineered automotive roof racks and accessories to enhance the outdoor enthusiast’s overlanding experience. Founded in 2005, our MAXTRAX brand offers high-quality overlanding and off-road vehicle recovery and extraction tracks for the overland and off-road market.

Clarus, incorporated in Delaware in 1991, acquired Black Diamond Equipment, Ltd. (“Black Diamond Equipment”) in May 2010 and changed its name to Black Diamond, Inc. in January 2011. In October 2012, we acquired PIEPS Holding GmbH and its subsidiaries (collectively, “PIEPS”). On August 14, 2017, the Company changed its name from Black Diamond, Inc. to Clarus Corporation and its stock ticker symbol from “BDE” to “CLAR” on the NASDAQ stock exchange.

On August 21, 2017, the Company acquired Sierra Bullets, L.L.C. (“Sierra”). On November 6, 2018, the Company acquired the assets of SKINourishment, Inc. (“SKINourishment”). On October 2, 2020, the Company completed the acquisition of certain assets and liabilities constituting the Barnes business (“Barnes”). On July 1, 2021, the Company completed the acquisition of Australia-based Rhino-Rack Holdings Pty Ltd (“Rhino-Rack”). On December 1, 2021, the Company completed the acquisition of Australia-based MaxTrax Australia Pty Ltd (“MAXTRAX”).

On August 6, 2018, the Company announced that its Board of Directors approved the initiation of a quarterly cash dividend program of $0.025 per share of the Company’s common stock (the “Quarterly Cash Dividend”) or $0.10 per share on an annualized basis. The declaration and payment of future Quarterly Cash Dividends is subject to the discretion of and approval of the Company’s Board of Directors. On April 28, 2023, the Company announced that its Board of Directors approved the payment on May 19, 2023 of the Quarterly Cash Dividend of $0.025 to the record holders of shares of the Company’s common stock as of the close of business on May 8, 2023.

Impact of COVID-19

The global outbreak of COVID-19 was declared a pandemic by the World Health Organization and a national emergency by each of the U.S., European, and Australian governments in March 2020, with governments world-wide implementing safety measures restricting travel and requiring citizen lockdowns and self-confinements for quarantining purposes. During the years ended December 31, 2020, 2021, and 2022, this had negatively affected the U.S., European, Australian and global economies, disrupted global supply chains, and resulted in significant transport restrictions and disruption of global financial markets.

An outbreak of disease or similar public health threat, such as the COVID-19 pandemic, could have, and in the case of the COVID-19 pandemic has had and may continue to have a significant impact on the global supply chain, with restrictions and limitations on related activities causing disruption and delay, along with increased raw material, storage, and shipping costs. Any of these disruptions and delays may strain domestic and international supply chains, which could negatively affect the flow or availability of certain critical raw materials and finished good products that the Company relies upon. Furthermore, the foregoing impacts may significantly increase demand from online sales channels, including our website, and could impact our logistical operations, including our fulfillment and shipping functions, which may result in periodic delays in the delivery of our products.

We expect that an outbreak of disease or similar public health threat, such as the COVID-19 pandemic, could have, and in the case of the COVID-19 pandemic may continue to have, an impact on the Company’s sales and profitability in future periods. The duration of these trends and the magnitude of such impacts cannot be precisely estimated at this time, as they are affected by a number of factors (some of which are outside management’s control), including those presented in Part I, Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2022.

22

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

Critical Accounting Policies and Use of Estimates

Management’s discussion of our financial condition and results of operations is based on the consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The preparation of the consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements. Estimates also affect the reported amounts of revenues and expenses during the reporting periods. Our critical accounting policies that require the use of estimates and assumptions were discussed in detail in our Annual Report on Form 10-K for the year ended December 31, 2022. We base our estimates on historical experience and other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates.

There have been no significant changes to our critical accounting policies as described in our Annual Report on Form 10-K for the year ended December 31, 2022.

Accounting Pronouncements Issued Not Yet Adopted

None

‎

23

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

Results of Operations

Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022

The following presents a discussion of operations for the three months ended March 31, 2023, compared with the three months ended March 31, 2022.

| Three Months Ended
| March 31, 2023 |  | March 31, 2022
Sales |  |  |  |  |
Domestic sales | $ | 44,916 |  | $ | 62,307
International sales |  | 52,468 |  |  | 50,969
Total sales |  | 97,384 |  |  | 113,276
Cost of goods sold |  | 61,363 |  |  | 69,024
Gross profit |  | 36,021 |  |  | 44,252
Operating expenses |  |  |  |  |
Selling, general and administrative |  | 32,819 |  |  | 34,175
Transaction costs |  | 74 |  |  | 1,201
Contingent consideration (benefit) expense |  | (1,565) |  |  | 763
Total operating expenses |  | 31,328 |  |  | 36,139
Operating income |  | 4,693 |  |  | 8,113
Other income (expense) |  |  |  |  |
Interest expense, net |  | (2,746) |  |  | (1,116)
Other, net |  | 85 |  |  | (67)
Total other expense, net |  | (2,661) |  |  | (1,183)
Income before income tax |  | 2,032 |  |  | 6,930
Income tax expense |  | 434 |  |  | 1,621
Net income | $ | 1,598 |  | $ | 5,309

Sales

Total sales decreased $15,892, or 14.0%, to $97,384 during the three months ended March 31, 2023, compared to total sales of $113,276 during the three months ended March 31, 2022. The decrease in sales was primarily attributable to a decrease in sales at the Adventure and Precision Sport segments of $11,133 and $6,012, respectively, partially offset by an increase in sales at the Outdoor segment of $1,253.

Sales in the Adventure segment decreased due to lower consumer demand given the challenging market conditions and the difficult macro-environment in both Australia and North America. Included in the Adventure segment decrease in sales is $968 of foreign exchange impact due to the strengthening of the U.S. dollar against foreign currencies during the three months ended March 31, 2023, compared to the prior period. Sales in the Precision Sport segment decreased due to ongoing supply chain challenges limiting ammunition sales. Sales in the Outdoor segment increased due to growth in the direct-to-consumer channels, and European and IGD markets, nearly offset by continued weakness at the Company’s key North American retail accounts. Increases in sales in the Outdoor segment were partially offset by $1,391 of foreign exchange impact due to the strengthening of the U.S. dollar against foreign currencies during the three months ended March 31, 2023, compared to the prior period.

Domestic sales decreased $17,391, or 27.9%, to $44,916 during the three months ended March 31, 2023, compared to domestic sales of $62,307 during the three months ended March 31, 2022. The decrease in sales was primarily attributable to a decrease in sales at the Precision Sport, Adventure, and Outdoor segments of $6,724, $6,603, and $4,064, respectively.

24

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

International sales increased $1,499, or 2.9%, to $52,468 during the three months ended March 31, 2023, compared to international sales of $50,969 during the three months ended March 31, 2022. The increase in sales was primarily attributable to an increase in sales at the Outdoor and Precision Sport segments of $5,317 and $712, respectively, partially offset by a decrease in sales at the Adventure segment of $4,530. Sales in the Outdoor and Adventure segments were reduced by $1,391 and $968, respectively, of foreign exchange impact due to the strengthening of the U.S. dollar against foreign currencies during the three months ended March 31, 2023, compared to the prior period.

Cost of Goods Sold

Cost of goods sold decreased $7,661, or 11.1%, to $61,363 during the three months ended March 31, 2023, compared to cost of goods sold of $69,024 during the three months ended March 31, 2022. The decrease in cost of goods sold was primarily attributable to a decrease in the number of units sold.

Gross Profit

Gross profit decreased $8,231, or 18.6%, to $36,021 during the three months ended March 31, 2023, compared to gross profit of $44,252 during the three months ended March 31, 2022. Gross margin was 37.0% during the three months ended March 31, 2023, compared to a gross margin of 39.1% during the three months ended March 31, 2022. Gross margin during the three months ended March 31, 2023, decreased compared to the prior year due to changes in channel and product mix of 2.2%, unfavorable foreign currency exchange movement of 1.5%, and a 1.3% negative impact due to higher inventory reserves. Channel and product mix were impacted by lower open-to-buys from the Company’s key North American retail partners in the Outdoor segment which negatively impacted gross margin. The decreases were partially offset by easing freight costs which positively impacted gross margin by 2.9%.

Selling, General and Administrative

Selling, general, and administrative expenses decreased $1,356, or 4.0%, to $32,819 during the three months ended March 31, 2023, compared to selling, general and administrative expenses of $34,175 during the three months ended March 31, 2022. The decrease is primarily due to a decrease in stock compensation of $2,034 during the three months ended March 31, 2023, compared to the prior year. The decrease was partially offset by an increase in administrative expense at the Outdoor segment of $1,824, primarily related to a higher investment in employee costs and the direct-to-consumer channel. Additionally, the Company incurred lower costs at the Adventure segment of $1,049 primarily related to disciplined cost management and a decrease in amortization expense.

Transaction Costs

Transaction expense decreased to $74 during the three months ended March 31, 2023, compared to transaction costs of $1,201 during the three months ended March 31, 2022, which consisted of expenses related to the Company’s various acquisition efforts.

Contingent Consideration (Benefit) Expense

Contingent consideration changed to a benefit of $1,565 during the three months ended March 31, 2023, compared to $763 contingent consideration expense during the three months ended March 31, 2022, which consisted of changes in the estimated fair value of contingent consideration liabilities associated with our acquisition of MAXTRAX in 2021.

Interest Expense, net

Interest expense, net increased to $2,746 during the three months ended March 31, 2023, compared to interest expense, net of $1,116 during the three months ended March 31, 2022. The increase in interest expense recognized during the three months ended March 31, 2023 was primarily associated with the increase in interest rates during the period compared to the prior year.

Other, net

Other, net, increased by $152, or 226.9%, to $85 during the three months ended March 31, 2023, compared to other, net of $(67) during the three months ended March 31, 2022. The change in other, net, was primarily attributable to a decrease in remeasurement losses recognized on the Company’s foreign denominated accounts receivable and accounts payable, which was partially offset by changes in mark-to-market adjustments on non-hedged foreign currency contracts during the three months ended March 31, 2023.

25

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

Income Taxes

Income tax expense decreased by $1,187, or 73.2%, to $434 during the three months ended March 31, 2023, compared to income tax expense of $1,621 during the same period in 2022. Our effective income tax rate was a benefit of 21.4% for the three months ended March 31, 2023, and differed compared to the statutory tax rates primarily due to the impact of stock compensation, research and experimentation expenditures and credits, and discrete stock option windfall benefits. For the three months ended March 31, 2022, our effective income tax rate was 23.4% and differed compared to the statutory tax rates due to the impact of foreign earnings taxed at applicable statutory rates and permanent book to tax differences related to incentive stock options and officer compensation limitations.

Liquidity and Capital Resources

Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022

Our primary ongoing funding requirements are for working capital, expansion of our operations (both organically and through acquisitions) and general corporate needs, as well as investing activities associated with the various brands. We plan to fund these activities through a combination of our future operating cash flows and borrowings on our revolving credit facility which had approximately $61,000 available to borrow at March 31, 2023, while currently maintaining compliance with the consolidated total leverage ratio per the Restated Credit Agreement of 3.75 to 1. We believe that our liquidity requirements and contractual obligations for at least the next 12 months will be adequately covered by cash provided by operations and our existing revolving credit facility. Additionally, long-term contractual obligations are also currently expected to be funded from cash from operations and availability under our existing credit facilities. For additional information regarding the Company’s existing credit facilities, see the section titled “Credit Agreement” below.

At March 31, 2023, we had total cash of $10,310, compared to a cash balance of $12,061 at December 31, 2022. At March 31, 2023, the Company had $6,108 of the $10,310 in cash held by foreign entities, of which $4,528 is considered permanently reinvested.

The following presents a discussion of cash flows for the condensed consolidated three months ended March 31, 2023 compared with the condensed consolidated three months ended March 31, 2022.

| Three Months Ended
| March 31, 2023 |  | March 31, 2022
Net cash provided by (used in) operating activities | $ | 3,199 |  | $ | (10,795)
Net cash used in investing activities |  | (1,383) |  |  | (1,900)
Net cash (used in) provided by financing activities |  | (3,138) |  |  | 8,467
Effect of foreign exchange rates on cash |  | (429) |  |  | 1,214
Change in cash |  | (1,751) |  |  | (3,014)
Cash, beginning of year |  | 12,061 |  |  | 19,465
Cash, end of period | $ | 10,310 |  | $ | 16,451

Net Cash From Operating Activities

Net cash provided by operating activities was $3,199 during the three months ended March 31, 2023, compared to net cash used in operating activities of $10,795 during the three months ended March 31, 2022. The change in net cash provided by (used in) operating activities during 2023 is primarily due to a decrease in cash outflows related to working capital of $23,517, partially offset by an increase in contingent consideration benefit, and a decrease in stock compensation during the three months ended March 31, 2023, compared to the same period in 2022.

26

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

Free cash flow, defined as net cash provided by (used in) operating activities less capital expenditures, of $1,728 was generated during the three months ended March 31, 2023 compared to $(12,695) used during the same period in 2022. The Company believes that the non-GAAP measure, free cash flow, provides an understanding of the capital required by the Company to expand its asset base. A reconciliation of free cash flows to the nearest comparable GAAP financial measure is set forth below:

| Three Months Ended
| March 31, 2023 |  | March 31, 2022
Net cash provided by (used in) operating activities | $ | 3,199 |  | $ | (10,795)
Purchase of property and equipment |  | (1,471) |  |  | (1,900)
Free cash flow | $ | 1,728 |  | $ | (12,695)

Net Cash From Investing Activities

Net cash used in investing activities was $1,383 during the three months ended March 31, 2023, compared to $1,900 during the three months ended March 31, 2022. The decrease in cash used during the three months ended March 31, 2023 is primarily due to a decrease in purchases of property and equipment, compared to the same period in 2022.

Net Cash From Financing Activities

Net cash used in financing activities was $3,138 during the three months ended March 31, 2023, compared to net cash provided by financing activities of $8,467 during the three months ended March 31, 2022. The decrease in cash provided during the three months ended March 31, 2023, compared to the same period in 2022 was primarily due to a decrease in net proceeds to the revolving line of credit and term loan.

Net Operating Loss

As of December 31, 2022, the Company had net operating loss carryforwards (“NOLs”) and research and experimentation credit for U.S. federal income tax purposes of $17,663 and $2,651, respectively. The Company believes its U.S. Federal NOLs will substantially offset its future U.S. Federal income taxes until expiration. The majority of the Company’s pre-tax income is currently earned and expected to be earned in the U.S., or taxed in the U.S. as Subpart F income and will be offset with the NOLs. The Company has $17,663 of NOLs, of which, $1,851 expire on December 31, 2023. These NOLs are subject to compliance with Section 382 of the Internal Revenue Code of 1986, as amended.

As of December 31, 2022, the Company’s gross deferred tax asset was $32,972. The Company has recorded a valuation allowance of $3,323, resulting in a net deferred tax asset of $29,649, before deferred tax liabilities of $30,243. The Company has provided a valuation allowance against a portion of the net deferred tax assets as of December 31, 2022, because the ultimate realization of those assets does not meet the more-likely-than-not criteria. The majority of the Company’s deferred tax assets consist of net operating loss carryforwards for federal tax purposes. If a change in control were to occur, these could be limited under Section 382 of the Internal Revenue Code of 1986 (“Code”), as amended.

Credit Agreement

As of March 31, 2023, the Company had drawn $18,538 on the revolving loan and $118,750 was outstanding under the term loan. Approximately $61,000 in additional funds were available to borrow on the revolving loan at March 31, 2023, while maintaining compliance with the consolidated total leverage ratio per the Restated Credit Agreement (as defined below) of 3.75 to 1. As of March 31, 2023, the interest rates on the revolving loan and term loan commitments were approximately 6.8%. The Company was in compliance with the debt covenants set forth in the Restated Credit Agreement as of March 31, 2023.

On April 18, 2022 (the “Effective Date”), the Company, Black Diamond Retail, Inc., Black Diamond Retail – Alaska, LLC, Sierra Bullets, L.L.C., SKINourishment, LLC, Black Diamond Retail – Colorado, LLC, Black Diamond Retail – Montana, LLC, Black Diamond Retail – Wyoming, LLC, Barnes Bullets-Mona, LLC, Black Diamond Retail – Oregon, LLC, Black Diamond Retail – Vermont, LLC (collectively with the Company, the “Borrowers”) and the other loan parties party thereto (together with the Borrowers, each a “Loan Party”, and collectively, the “Loan Parties”) entered into an Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”) and the lenders party thereto (the “Restated Credit Agreement”) pursuant to which the existing Credit Agreement, dated as of May 3, 2019 (as amended prior to the Effective Date, the “Existing Credit Agreement”) by and among the Company, the lenders and loan parties from time to time party thereto and the Administrative Agent

27

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

was amended and restated in its entirety. Each of the Loan Parties, other than the Company, is a direct or indirect subsidiary of the Company.

The Restated Credit Agreement provides for borrowings of up to $300,000 under a secured revolving credit facility (the “Revolving Loans”) (including up to $5,000 for letters of credit), and borrowings of up to $125,000 under a secured term loan facility (the “Term Loans”). The Restated Credit Agreement also permits the Borrowers, subject to certain requirements, to arrange with lenders for an aggregate of up to $175,000 of additional revolving and/or term loan commitments (both of which are currently uncommitted), for potential aggregate revolving and term loan commitments under the Restated Credit Agreement of up to $600,000. The proceeds of loans made under the Restated Credit Agreement may be used for working capital and general corporate purposes, including acquisitions permitted under the Restated Credit Agreement. The Restated Credit Agreement matures on April 18, 2027 (the “Maturity Date”), at which time the revolving commitments thereunder will terminate and all outstanding Revolving Loans and Term Loans, together with all accrued and unpaid interest thereon, must be repaid.

The Term Loans were fully drawn on the Effective Date and cannot be reborrowed. The Restated Credit Agreement provides for quarterly amortization payments of the Term Loans on the last business day of each March, June, September and December, commencing on June 30, 2022. Through and including the payment due on March 31, 2023, the scheduled amortization payment is $1,563 per quarter, and each scheduled amortization payment due thereafter through the Maturity Date is $3,125 per quarter.

The Borrowers may elect to have the Revolving Loans and Term Loans under the Restated Credit Agreement bear interest at an applicable rate plus either:

(i) in the case of alternate base rate borrowings, a rate per annum generally equal to the greatest of:

| (a) | the prime rate in effect on such day;

| (b) | 0.50% plus the greater of the Federal Reserve Bank of New York’s effective federal funds rate or the Federal Reserve Bank of New York’s overnight bank funding rate in effect on such day; and

| (c) | 1.00% plus the adjusted term SOFR rate for a 1-month interest period;

provided that, in certain circumstances where the alternate base rate is being used as an alternate rate of interest, the alternate base rate shall be determined only according to (a) and (b), and shall be subject to a 1.00% floor; or

(ii) in the case of term benchmark borrowings, a rate per annum as follows:

| (a) | for borrowings denominated in U.S. Dollars, the term SOFR rate (based on one, three or six-month interest periods) plus 0.10%, subject to a 0.00% floor; or

| (b) | for borrowings denominated in a Foreign Currency, the applicable rate for such Foreign Currency set forth in the Restated Credit Agreement.

The applicable rate for these borrowings will range from 0.50% to 1.625% per annum, in the case of alternate base rate borrowings, and 1.50% to 2.625% per annum, in the case of term benchmark borrowings. The applicable rate was initially 0.875% per annum, in the case of alternate base rate borrowings, and 1.875% per annum, in the case of term benchmark borrowings, however, these initial applicable rates may be adjusted from time to time based upon the level of the Company’s consolidated total leverage ratio, which is more fully discussed in the Restated Credit Agreement. If one or more of the above interest rates are not determinable, or under certain other circumstances set forth in the Restated Credit Agreement, a substitute or alternative interest rate may apply under the Restated Credit Agreement.

The Restated Credit Agreement also requires the Borrowers to pay a commitment fee on the unused portion of the revolving loan commitments. Such commitment fee will range between 0.15% and 0.30% per annum, and is also based upon the level of the Company’s consolidated total leverage ratio, which is more fully discussed in the Restated Credit Agreement. The Company is also obligated to pay other customary closing fees, arrangement fees, administration fees and letter of credit fees for a credit facility of this size and type.

The Restated Credit Agreement contains customary affirmative and negative covenants, including limitations on the ability of the Company and its subsidiaries to perform the following, subject to certain customary exceptions, qualifications and “baskets”: (i) incur additional debt; (ii) create liens; (iii) engage in mergers, consolidations, certain divisions, liquidations or dissolutions other than in certain permitted instances as described in the Restated Credit Agreement; (iv) substantially change the business conducted by the

28

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

Company and its subsidiaries; (v) make certain investments, loans, advances, guarantees and acquisitions other than in certain permitted instances as described in the Restated Credit Agreement; (vi) sell assets; (vii) pay dividends or make distributions or other restricted payments if certain conditions in the Restated Credit Agreement are not fulfilled; (viii) prepay other indebtedness; (ix) engage in certain transactions with affiliates; (x) enter into agreements that restrict dividends from subsidiaries or the ability of subsidiaries to grant liens upon their assets; (xi) amend certain charter documents and material agreements governing subordinated indebtedness; (xii) permit the consolidated total leverage ratio, which is to be determined for each quarter end on a trailing twelve month basis, from exceeding a limit of 3.75 to 1, provided, that, subject to certain terms and conditions set forth in the Restated Credit Agreement, so long as no Event of Default (as defined in the Restated Credit Agreement) exists at such time or would result therefrom, the Company may elect to increase the maximum consolidated total leverage ratio permitted under the Restated Credit Agreement to 4.25:1.00 for a period of four consecutive fiscal quarters in connection with any acquisition permitted under the Restated Credit Agreement for which the aggregate consideration is greater than or equal to $60,000; and (xiii) permit the consolidated fixed charge coverage ratio, which is to be determined for each quarter end on a trailing twelve month basis, to be less than 1.25 to 1.

The Restated Credit Agreement also contains customary events of default, including, but not limited to: (i) failure to pay amounts due under the Restated Credit Agreement; (ii) materially incorrect representations and warranties; (iii) failure to comply with covenants; (iv) change of control; and (v) default under other indebtedness aggregating at least $3,000.

The obligations of each Loan Party under the Restated Credit Agreement are guaranteed by each other Loan Party. All obligations under the Restated Credit Agreement, and the guarantees of those obligations (as well as banking services obligations and certain swap agreements), are secured by pledges and liens on 100% of the equity interests of domestic subsidiaries, either 100% or 65% of the equity interests of certain foreign subsidiaries, and the accounts receivable, inventory, intellectual property and certain real property or other assets of the Loan Parties pursuant to (i) a Pledge and Security Agreement, dated as of May 3, 2019, by and among certain of the Loan Parties and the Administrative Agent (as amended from time to time prior to the Effective Date, the “PSA”), (ii) a General Security Deed, dated as of August 30, 2021, by and among certain of the Loan Parties and the Administrative Agent (the “Oscar GSD”), (iii) a General Security Deed, dated as of January 31, 2022, by and among certain of the Loan Parties and the Administrative Agent (the “Simpson GSD”) or (iv) a mortgage or other applicable security agreement or instrument. Each of the PSA, the Oscar GSD and the Simpson GSD was reaffirmed by the Loan Parties on the Effective Date pursuant to a Reaffirmation Agreement dated as of the Effective Date by and among the Administrative Agent and the Loan Parties (the “Reaffirmation Agreement”) pursuant to which each Loan Party ratified and reaffirmed its obligations to the Lenders in connection with entering into the Restated Credit Agreement.

Off-Balance Sheet Arrangements

We do not engage in any transactions or have relationships or other arrangements with unconsolidated entities. These include special purpose and similar entities or other off-balance sheet arrangements. We also do not engage in energy, weather or other commodity-based contracts.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There has not been any material change in the market risk disclosure contained in our Annual Report on Form 10-K for the year ended December 31, 2022.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company’s management carried out an evaluation, under the supervision and with the participation of the Company’s Executive Chairman and Chief Financial Officer, its principal executive officer and principal financial officer, respectively, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15I and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)) as of March 31, 2023, pursuant to Exchange Act Rule 13a-15. Such disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company is accumulated and communicated to the appropriate management on a basis that permits timely decisions regarding disclosure. Based upon that evaluation, the Company’s Executive Chairman and Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of March 31, 2023, were effective.

## Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting that occurred during the three months ended March 31, 2023, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

29

CLARUS CORPORATION

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDIN GS

Legal Proceedings

The Company is involved in various legal disputes and other legal proceedings that arise from time to time in the ordinary course of business. Based on currently available information, the Company does not believe that the disposition of any of the legal disputes the Company or its subsidiaries is currently involved in will have a material adverse effect upon the Company’s consolidated financial condition, results of operations or cash flows. It is possible that, as additional information becomes available, the impact on the Company of an adverse determination could have a different effect.

Litigation

The Company is involved in various lawsuits arising from time to time that the Company considers ordinary routine litigation incidental to its business. Amounts accrued for litigation matters represent the anticipated costs (damages and/or settlement amounts) in connection with pending litigation and claims and related anticipated legal fees for defending such actions, which legal fees are expensed as incurred. The costs are accrued when it is both probable that a liability has been incurred and the amount can be reasonably estimated. The accruals are based upon the Company’s assessment, after consultation with counsel (if deemed appropriate), of probable loss based on the facts and circumstances of each case, the legal issues involved, the nature of the claim made, the nature of the damages sought and any relevant information about the plaintiffs and other significant factors that vary by case. When it is not possible to estimate a specific expected cost to be incurred, the Company evaluates the range of probable loss and records the minimum end of the range. Based on currently available information, the Company does not believe that it is reasonably possible that the disposition of any of the legal disputes the Company or its subsidiaries is currently involved in will have a material adverse effect upon the Company’s consolidated financial condition, results of operations or cash flows. There is a reasonable possibility of loss from contingencies in excess of the amounts accrued by the Company in the accompanying condensed consolidated balance sheets; however, the actual amounts of such possible losses cannot currently be reasonably estimated by the Company at this time. It is possible that, as additional information becomes available, the impact on the Company could have a different effect.

Product Liability

As a consumer goods manufacturer and distributor, the Company faces the risk of product liability and related lawsuits involving claims for substantial money damages, product recall actions and higher than anticipated rates of warranty returns or other returns of goods. The Company is therefore vulnerable to various personal injury and property damage lawsuits relating to its products and incidental to its business.

Based on current information, there are no pending product liability claims and lawsuits of the Company, which the Company believes in the aggregate, will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

ITEM 1A. RISK FACTORS

There have been no material changes in our risk factors from those disclosed in Part I, Item 1A. of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
‎

30

CLARUS CORPORATION

ITEM 6. EXHIBITS

Exhibit |  | Description
10.1 |  | Employment Agreement, dated as of March 14, 2023, between Clarus Corporation and Warren B. Kanders (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 16, 2023, and incorporated herein by reference).
10.2 |  | Separation Agreement, dated as of March 31, 2023, between Clarus Corporation and John Walbrecht (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 4, 2023, and incorporated herein by reference).
31.1 |  | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. *
31.2 |  | Certification of Principal Financial Officer pursuant to Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. *
32.1 |  | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. **
32.2 |  | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. **
101.INS |  | XBRL Instance Document *
101.SCH |  | XBRL Taxonomy Extension Schema Document *
101.CAL |  | XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF |  | XBRL Taxonomy Extension Definition Linkbase Document *
101.LAB |  | XBRL Taxonomy Extension Label Linkbase Document *
101.PRE |  | XBRL Taxonomy Extension Presentation Linkbase Document *
104 |  | Cover Page Interactive Data File – formatted as Inline XBRL and contained in Exhibit 101
* |  | Filed herewith
** |  | Furnished herewith

‎

31

CLARUS CORPORATION

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | CLARUS CORPORATION
Date: May 1, 2023 |  | By: | /s/ Warren B. Kanders
|  | Name: | Warren B. Kanders
|  | Title: | Executive Chairman
|  |  | (Principal Executive Officer)
Date: May 1, 2023 |  | By: | /s/ Michael J. Yates
|  | Name: | Michael J. Yates
|  | Title: | Chief Financial Officer
|  |  | (Principal Financial Officer and Principal Accounting Officer)

32